Semnani et al. [35] reported significant increases in the markers of remyelination, proteolipid protein, and oligodendrocyte transcription factor 1 in a multiple sclerosis model, indicating robust remyelination after 2 and 4 weeks of EGCG treatment compared to controls. The gene discussed is OLIG1; the disease is multiple sclerosis.